Department of Anesthesia, McGill University, Montreal, QC, Canada.
Department of Anesthesia, McGill University, Montreal, QC, Canada.
Br J Anaesth. 2020 Mar;124(3):314-323. doi: 10.1016/j.bja.2019.11.033. Epub 2020 Jan 28.
In surgical patients undergoing general anaesthesia, coughing at the time of extubation is common and can result in potentially dangerous complications. We performed a systematic review and meta-analysis to assess the efficacy and safety of i.v. lidocaine administration during the perioperative period to prevent cough and other airway complications.
We searched Medical Literature Analysis and Retrieval System, Excerpta Medica database, and Cochrane Central Register of Controlled Trials for RCTs comparing the perioperative use of i.v. lidocaine with a control group in adult patients undergoing surgery under general anaesthesia. The RCTs were assessed using risk-of-bias assessment, and the quality of evidence was assessed using Grading of Recommendations, Assessment, Development and Evaluations (GRADE).
In 16 trials (n=1516), the administration of i.v. lidocaine compared with placebo or no treatment led to large reductions in post-extubation cough (risk ratio [RR]: 0.64; 95% confidence interval [CI]: 0.48-0.86) and in postoperative sore throat at 1 h (RR: 0.46; 95% CI: 0.32-0.67). There was no difference in incidence of laryngospasm (risk difference [RD]: 0.02; 95% CI: -0.07 to 0.03) or incidence of adverse events related to the use of lidocaine.
The use of i.v. lidocaine perioperatively decreased airway complications, including coughing and sore throat. There was no associated increased risk of harm.
在全身麻醉下接受手术的患者中,拔管时咳嗽很常见,可能导致潜在的危险并发症。我们进行了系统评价和荟萃分析,以评估围手术期静脉给予利多卡因预防咳嗽和其他气道并发症的疗效和安全性。
我们检索了医学文献分析与检索系统、文摘医学数据库和 Cochrane 对照试验中心,以比较全身麻醉下手术的成年患者围手术期使用静脉利多卡因与对照组的 RCT。使用风险偏倚评估对 RCT 进行评估,并使用推荐评估、制定与评价分级(GRADE)评估证据质量。
在 16 项试验(n=1516)中,与安慰剂或无治疗相比,静脉给予利多卡因可显著减少拔管后咳嗽(风险比 [RR]:0.64;95%置信区间 [CI]:0.48-0.86)和术后 1 小时咽痛(RR:0.46;95% CI:0.32-0.67)。喉痉挛的发生率(差异风险 [RD]:0.02;95% CI:-0.07 至 0.03)或与使用利多卡因相关的不良事件发生率无差异。
围手术期使用静脉利多卡因可减少气道并发症,包括咳嗽和咽痛,且不会增加相关伤害的风险。